Exons 2 and 3 of CanA1 have been replaced by loxP cassette containing a wGMR.PH marker. An attP site is present downstream of the 3 'loxP site to allow future integration of constructs into the knock-out site.
abnormal locomotor behavior
abnormal sleep
CanA1KO mutants exhibit a decrease in total daily activity and an increase in total sleep, both in LD and DD conditions.